Targeting the transforming growth factor-β signaling pathway in human cancer
- 10 December 2009
- journal article
- review article
- Published by Informa UK Limited in Expert Opinion on Investigational Drugs
- Vol. 19 (1), 77-91
- https://doi.org/10.1517/13543780903382609
Abstract
The transforming growth factor-ß (TGF-β) signaling pathway plays a pivotal role in diverse cellular processes. TGF-β switches its role from a tumor suppressor in normal or dysplastic cells to a tumor promoter in advanced cancers. It is widely believed that the Smad-dependent pathway is involved in TGF-β tumor-suppressive functions, whereas activation of Smad-independent pathways, coupled with the loss of tumor-suppressor functions of TGF-β, is important for its pro-oncogenic functions. TGF-β signaling has been considered a useful therapeutic target. The discovery of oncogenic actions of TGF-β has generated a great deal of enthusiasm for developing TGF-β signaling inhibitors for the treatment of cancer. The challenge is to identify the group of patients where targeted tumors are not only refractory to TGF-β-induced tumor suppressor functions but also responsive to the tumor-promoting effects of TGF-β. TGF-β pathway inhibitors, including small and large molecules, have now entered clinical trials. Preclinical studies with these inhibitors have shown promise in a variety of different tumor models. Here, we focus on the mechanisms of signaling and specific targets of the TGF-β pathway that are critical effectors of tumor progression and invasion. This report also examines the therapeutic intervention of TGF-ß signaling in human cancers.Keywords
This publication has 119 references indexed in Scilit:
- Targeting transforming growth factor-β signaling in liver metastasis of colon cancerCancer Letters, 2009
- TGFβ in CancerCell, 2008
- SMAD proteins control DROSHA-mediated microRNA maturationNature, 2008
- Mechanisms of Hepatic FibrogenesisGastroenterology, 2008
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote MetastasisCancer Cell, 2008
- Loss of TGFβ Signaling Destabilizes Homeostasis and Promotes Squamous Cell Carcinomas in Stratified EpitheliaCancer Cell, 2007
- Inactivation of TGF-β signaling in hepatocytes results in an increased proliferative response after partial hepatectomyOncogene, 2005
- Development of TGF-β signalling inhibitors for cancer therapyNature Reviews Drug Discovery, 2004
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003